Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS30031535HIVENSG00000149554.15protein_codingCHEK1NoYes1111E7EPP6
O14757
TVIS30031536HIVENSG00000149554.15protein_codingCHEK1NoYes1111E7EPP6
O14757
TVIS30031537HIVENSG00000149554.15protein_codingCHEK1NoYes1111E7EPP6
O14757
TVIS30031538HIVENSG00000149554.15protein_codingCHEK1NoYes1111E7EPP6
O14757
TVIS20049706HPVENSG00000149554.15protein_codingCHEK1NoYes1111E7EPP6
O14757
TVIS44008453HTLV-1ENSG00000149554.15protein_codingCHEK1NoYes1111E7EPP6
O14757
TCGA Plot Options
Drug Information
GeneCHEK1
DrugBank IDDB12284
Drug NameLY-2608204
Target IDBE0003382
UniProt IDO14757
Regulation Typeinhibitor
PubMed IDs32610557
CitationsYang CY, Liu CR, Chang IY, OuYang CN, Hsieh CH, Huang YL, Wang CI, Jan FW, Wang WL, Tsai TL, Liu H, Tseng CP, Chang YS, Wu CC, Chang KP: Cotargeting CHK1 and PI3K Synergistically Suppresses Tumor Growth of Oral Cavity Squamous Cell Carcinoma in Patient-Derived Xenografts. Cancers (Basel). 2020 Jun 29;12(7). pii: cancers12071726. doi: 10.3390/cancers12071726.
GroupsInvestigational
Direct ClassificationPhenylacetamides
SMILESO=C(NC1=NC=C(SCCN2CCCC2)S1)[C@@]1(C[C@H]1C1CCCCC1)C1=CC=C(C=C1)S(=O)(=O)C1CC1
Pathways
PharmGKB
ChEMBL